Reuters logo
BRIEF-MyoKardia expects to initiate next trial of MYK-491 in DCM patients by year-end
September 27, 2017 / 11:46 AM / 2 months ago

BRIEF-MyoKardia expects to initiate next trial of MYK-491 in DCM patients by year-end

Sept 27 (Reuters) - MyoKardia Inc

* MyoKardia provides update on MYK-491 clinical progress

* MyoKardia Inc - ‍next trial of MYK-491 in DCM patients expected to initiate by year-end​

* MyoKardia Inc says ‍MyoKardia intends to initiate a single ascending dose trial of MYK-491 in symptomatic DCM patients before year-end​

* MyoKardia Inc - ‍topline data of Myk-491 expected by early 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below